Elevation Oncology, Inc. (ELEV)

NASDAQ: ELEV · IEX Real-Time Price · USD

2.640

-0.030 (-1.12%)

At close: Jul 19, 2024, 4:00 PM

2.730

+0.090 (3.41%)

Pre-market: Jul 22, 2024, 8:59 AM EDT

Elevation Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	90.63	49.26	45.92	146.28	79.4	1.74
Short-Term Investments	13.42	33.85	44.36	0	0	0
Cash & Cash Equivalents	104.05	83.11	90.28	146.28	79.4	1.74
Cash Growth	40.74%	-7.95%	-38.28%	84.24%	4463.22%	-
Other Current Assets	3.84	4.86	2.7	3.14	1.39	0.17
Total Current Assets	107.89	87.96	92.98	149.42	80.79	1.91
Property, Plant & Equipment	0.05	0.06	0.1	0.04	0.06	0
Other Long-Term Assets	1.03	1.07	1.09	0.03	0.07	0
Total Long-Term Assets	1.07	1.13	1.18	0.07	0.12	0
Total Assets	108.96	89.09	94.16	149.49	80.91	1.91
Accounts Payable	0.44	0.51	6.36	5.65	5.68	0.46
Other Current Liabilities	1.9	3.64	9.33	3.14	1.11	0.14
Total Current Liabilities	2.33	4.15	15.69	8.79	6.79	0.6
Long-Term Debt	30.81	30.14	29.44	0	0	0
Other Long-Term Liabilities	0	0	0	0.01	0.02	0
Total Long-Term Liabilities	30.81	30.14	29.44	0.01	0.02	0
Total Liabilities	33.14	34.28	45.13	8.8	6.8	0.6
Total Debt	30.81	30.14	29.44	0	0	0
Debt Growth	4.08%	2.38%	-	-	-	-
Retained Earnings	-206.68	-195.97	-150.27	-55.19	-23.15	-5.88
Comprehensive Income	0	0.01	-0.16	0	0	0
Shareholders' Equity	75.82	54.81	49.03	140.7	-23.08	-5.87
Net Cash / Debt	73.24	52.97	60.85	146.28	79.4	1.74
Net Cash / Debt Growth	65.22%	-12.94%	-58.41%	84.24%	4463.22%	-
Net Cash Per Share	1.55	1.55	2.62	12.06	100.28	2.34
Working Capital	105.55	83.82	77.29	140.64	74	1.32
Book Value Per Share	1.60	1.61	2.11	11.60	-29.15	-7.89

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).